Labcorp Holdings Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Labcorp Holdings Inc's ROI in the third quarter of 2026?
Labcorp Holdings Inc achieved a return on average invested assets (ROI) of 6.24 % in its third quarter of 2026, which is below Labcorp Holdings Inc's average return on investment, which stands at 8.47%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 68 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1324, from total ROI ranking in the second quarter of 2026 at 1577.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	4.81 %	4.78 %	7.79 %	11.9 %	14.15 %
Y / Y Net Income Change TTM	17.33 %	31.26 %	79.15 %	180.24 %	404.95 %
Investment (TTM) in Millions	16,089	16,391	16,429	15,552	15,616
Return On Investment (TTM)	6.24 %	6.27 %	5.99 %	5.66 %	5.57 %
LH's Overall Ranking	# 1324	# 1577	# 1262	# 1317	# 1313
Seq. Investment Change TTM	0.74 %	1.69 %	1.46 %	0.84 %	0.71 %
Seq. Net Income Change TTM	0.13 %	6.45 %	7.41 %	2.49 %	12.02 %
Net Income (TTM) in Millions	1,005	1,004	943	878	856

LH Company Profile >> Back to LH Roi Comparisons >> See Annual LH Return On Investment

Return On Investment LH's Ranking
Within:	No.
Industry	# 7
Sector	# 69
Overall	# 1324

Return On Investment Statistics
High	Average	Low
17.21 %	8.47 %	-1.41 %
(Sep. 30, 2007)

Financial Statements
Labcorp Holdings Inc's III. Quarter Investments	$ 16,089 Millions	LH's Balance sheet
Labcorp Holdings Inc's III. Quarter Income	$ 263 Millions	Quarterly LH's Income Statement
LH's Income by Division		See LH's Income by Division

LH Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2021	(Dec 31 2020) 2020
Total Investments in Millions	15,552	15,035	13,484	17,058	16,973
Y / Y Investment Growth	3.44 %	11.5 %	-20.95 %	0.5 %	10.42 %
Net Income in Millions	878	747	419	1,281	1,557
Y / Y Net Income Growth	17.48 %	78.22 %	-67.27 %	-17.75 %	88.75 %
Annual Return On Investment	5.64 %	4.97 %	3.11 %	7.51 %	9.17 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 5.64 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LH's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LH's Competitors
Subscribers only: Roi for Labcorp Holdings Inc's Suppliers
Subscribers only: Return On Investment for LH's Customers

Other Ratios
LH's Roa	LH's Inventory Turnover Ratio	LH's Growth Rates	LH's Dividend Statistics
	LH's Profitability Ratios	LH's Asset Turnover Ratio	LH's Dividend Growth
LH's Roe	LH's Valuation Ratios	LH's Financial Strength Ratios	LH's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Neurocrine Biosciences Inc	16.94 %
Krystal Biotech Inc	16.91 %
Vertex Pharmaceuticals Inc	16.63 %
Intuitive Surgical Inc	16.30 %
Hca Healthcare Inc	15.54 %
Kiniksa Pharmaceuticals International Plc	15.45 %
Amgen Inc	13.64 %
Carlisle Companies Incorporated	13.64 %
Bristol myers Squibb Company	13.59 %
3m Company	13.24 %
Beone Medicines Ltd	13.17 %
Regeneron Pharmaceuticals Inc	13.00 %
Abbvie Inc	12.87 %
Lantheus Holdings Inc	11.96 %
Msa Safety Inc	11.78 %
Inspire Medical Systems inc	11.63 %
Transmedics Group Inc	11.55 %
Bioventus Inc	11.26 %
Tenet Healthcare Corp	10.91 %
Bio rad Laboratories Inc	10.59 %
Lemaitre Vascular Inc	10.56 %
Johnson and Johnson	10.53 %
Encompass Health Corporation	10.41 %
Ani Pharmaceuticals Inc	9.61 %
Tactile Systems Technology Inc	9.27 %
Boston Scientific Corporation	9.14 %
Brightspring Health Services Inc	9.01 %
Stryker Corp	8.63 %
Pediatrix Medical Group Inc	8.37 %
Penumbra Inc	8.28 %

Date modified: 2026-10-31T09:56:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.